Guidance for Veracyte (VCYT)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2024 | N/A | N/A | $394.00M – 402.00M | $392.70M | = Maintained | Details |
2023 | N/A | N/A | $325.00M – 335.00M | $329.60M | = Maintained | Details |
2023 | N/A | N/A | $352.00M – 354.00M | $347.00M | = Maintained | Details |
2022 | N/A | N/A | $265.00M – 275.00M | $270.00M | = Maintained | Details |
2021 | N/A | N/A | $200.00M – 208.00M | $197.90M | = Maintained | Details |
Q1 2021 | N/A | N/A | $190.00M – 200.00M | $151.18M | = Maintained | Details |
2020 | N/A | N/A | $138.00M – 142.00M | $136.41M | = Maintained | Details |
2019 | N/A | N/A | $117.00M – 121.00M | $114.98M | = Maintained | Details |
2019 | N/A | N/A | $113.00M – 117.00M | $109.43M | = Maintained | Details |
2019 | N/A | N/A | $119.00M – 122.00M | $119.33M | = Maintained | Details |
2019 | N/A | N/A | $119.00M – 122.00M | $120.14M | = Maintained | Details |
2018 | N/A | N/A | $83.00B – 86.00B | $81.64B | = Maintained | Details |
2018 | N/A | N/A | $90.00M – 91.00M | $88.09M | = Maintained | Details |
2018 | N/A | N/A | $81.00M – 83.00M | $84.95M | = Maintained | Details |
Q3 2018 | N/A | N/A | $87.00M – 89.00M | $84.54M | = Maintained | Details |
2017 | N/A | N/A | $76.00M – 84.00M | N/A | = Maintained | Details |
Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
2016 | N/A | N/A | $59.00M – 63.00M | $62.90M | = Maintained | Details |
2015 | N/A | N/A | $48.00M – 53.00M | $59.10M | = Maintained | Details |
2015 | N/A | N/A | $48.00M – 53.00M | N/A | = Maintained | Details |